Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug based on CAR T-Cell Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global Drug based on CAR T-Cell Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug based on CAR T-Cell Market Perspective (2018-2029)
2.2 Global Drug based on CAR T-Cell Growth Trends by Region
2.2.1 Drug based on CAR T-Cell Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug based on CAR T-Cell Historic Market Size by Region (2018-2024)
2.2.3 Drug based on CAR T-Cell Forecasted Market Size by Region (2024-2029)
2.3 Drug based on CAR T-Cell Market Dynamics
2.3.1 Drug based on CAR T-Cell Industry Trends
2.3.2 Drug based on CAR T-Cell Market Drivers
2.3.3 Drug based on CAR T-Cell Market Challenges
2.3.4 Drug based on CAR T-Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drug based on CAR T-Cell by Players
3.1.1 Global Drug based on CAR T-Cell Revenue by Players (2018-2024)
3.1.2 Global Drug based on CAR T-Cell Revenue Market Share by Players (2018-2024)
3.2 Global Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug based on CAR T-Cell, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Drug based on CAR T-Cell Market Concentration Ratio
3.4.1 Global Drug based on CAR T-Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug based on CAR T-Cell Revenue in 2022
3.5 Global Key Players of Drug based on CAR T-Cell Head office and Area Served
3.6 Global Key Players of Drug based on CAR T-Cell, Product and Application
3.7 Global Key Players of Drug based on CAR T-Cell, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug based on CAR T-Cell Breakdown Data by Type
4.1 Global Drug based on CAR T-Cell Historic Market Size by Type (2018-2024)
4.2 Global Drug based on CAR T-Cell Forecasted Market Size by Type (2024-2029)
5 Drug based on CAR T-Cell Breakdown Data by Application
5.1 Global Drug based on CAR T-Cell Historic Market Size by Application (2018-2024)
5.2 Global Drug based on CAR T-Cell Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drug based on CAR T-Cell Market Size (2018-2029)
6.2 North America Drug based on CAR T-Cell Market Size by Type
6.2.1 North America Drug based on CAR T-Cell Market Size by Type (2018-2024)
6.2.2 North America Drug based on CAR T-Cell Market Size by Type (2024-2029)
6.2.3 North America Drug based on CAR T-Cell Market Share by Type (2018-2029)
6.3 North America Drug based on CAR T-Cell Market Size by Application
6.3.1 North America Drug based on CAR T-Cell Market Size by Application (2018-2024)
6.3.2 North America Drug based on CAR T-Cell Market Size by Application (2024-2029)
6.3.3 North America Drug based on CAR T-Cell Market Share by Application (2018-2029)
6.4 North America Drug based on CAR T-Cell Market Size by Country
6.4.1 North America Drug based on CAR T-Cell Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Drug based on CAR T-Cell Market Size by Country (2018-2024)
6.4.3 North America Drug based on CAR T-Cell Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Drug based on CAR T-Cell Market Size (2018-2029)
7.2 Europe Drug based on CAR T-Cell Market Size by Type
7.2.1 Europe Drug based on CAR T-Cell Market Size by Type (2018-2024)
7.2.2 Europe Drug based on CAR T-Cell Market Size by Type (2024-2029)
7.2.3 Europe Drug based on CAR T-Cell Market Share by Type (2018-2029)
7.3 Europe Drug based on CAR T-Cell Market Size by Application
7.3.1 Europe Drug based on CAR T-Cell Market Size by Application (2018-2024)
7.3.2 Europe Drug based on CAR T-Cell Market Size by Application (2024-2029)
7.3.3 Europe Drug based on CAR T-Cell Market Share by Application (2018-2029)
7.4 Europe Drug based on CAR T-Cell Market Size by Country
7.4.1 Europe Drug based on CAR T-Cell Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Drug based on CAR T-Cell Market Size by Country (2018-2024)
7.4.3 Europe Drug based on CAR T-Cell Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drug based on CAR T-Cell Market Size (2018-2029)
8.2 China Drug based on CAR T-Cell Market Size by Type
8.2.1 China Drug based on CAR T-Cell Market Size by Type (2018-2024)
8.2.2 China Drug based on CAR T-Cell Market Size by Type (2024-2029)
8.2.3 China Drug based on CAR T-Cell Market Share by Type (2018-2029)
8.3 China Drug based on CAR T-Cell Market Size by Application
8.3.1 China Drug based on CAR T-Cell Market Size by Application (2018-2024)
8.3.2 China Drug based on CAR T-Cell Market Size by Application (2024-2029)
8.3.3 China Drug based on CAR T-Cell Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Drug based on CAR T-Cell Market Size (2018-2029)
9.2 Asia Drug based on CAR T-Cell Market Size by Type
9.2.1 Asia Drug based on CAR T-Cell Market Size by Type (2018-2024)
9.2.2 Asia Drug based on CAR T-Cell Market Size by Type (2024-2029)
9.2.3 Asia Drug based on CAR T-Cell Market Share by Type (2018-2029)
9.3 Asia Drug based on CAR T-Cell Market Size by Application
9.3.1 Asia Drug based on CAR T-Cell Market Size by Application (2018-2024)
9.3.2 Asia Drug based on CAR T-Cell Market Size by Application (2024-2029)
9.3.3 Asia Drug based on CAR T-Cell Market Share by Application (2018-2029)
9.4 Asia Drug based on CAR T-Cell Market Size by Region
9.4.1 Asia Drug based on CAR T-Cell Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Drug based on CAR T-Cell Market Size by Region (2018-2024)
9.4.3 Asia Drug based on CAR T-Cell Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Drug based on CAR T-Cell Introduction
11.1.4 Novartis Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.1.5 Novartis Recent Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Drug based on CAR T-Cell Introduction
11.2.4 Gilead Sciences Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.2.5 Gilead Sciences Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Introduction
11.3.4 Bristol-Myers Squibb Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 J & J
11.4.1 J & J Company Details
11.4.2 J & J Business Overview
11.4.3 J & J Drug based on CAR T-Cell Introduction
11.4.4 J & J Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.4.5 J & J Recent Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Drug based on CAR T-Cell Introduction
11.5.4 JW Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.5.5 JW Therapeutics Recent Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Details
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite Drug based on CAR T-Cell Introduction
11.6.4 FOSUNKite Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.6.5 FOSUNKite Recent Developments
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Details
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Developments
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Details
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Introduction
11.8.4 CARsgen Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.8.5 CARsgen Therapeutics Recent Developments
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Details
11.9.2 Autolus Therapeutics Business Overview
11.9.3 Autolus Therapeutics Drug based on CAR T-Cell Introduction
11.9.4 Autolus Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.9.5 Autolus Therapeutics Recent Developments
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Details
11.10.2 Sorrento Therapeutics Business Overview
11.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Introduction
11.10.4 Sorrento Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.10.5 Sorrento Therapeutics Recent Developments
11.11 Mustang Bio
11.11.1 Mustang Bio Company Details
11.11.2 Mustang Bio Business Overview
11.11.3 Mustang Bio Drug based on CAR T-Cell Introduction
11.11.4 Mustang Bio Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.11.5 Mustang Bio Recent Developments
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Details
11.12.2 Bluebird Bio Business Overview
11.12.3 Bluebird Bio Drug based on CAR T-Cell Introduction
11.12.4 Bluebird Bio Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.12.5 Bluebird Bio Recent Developments
11.13 Cellectis
11.13.1 Cellectis Company Details
11.13.2 Cellectis Business Overview
11.13.3 Cellectis Drug based on CAR T-Cell Introduction
11.13.4 Cellectis Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.13.5 Cellectis Recent Developments
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Details
11.14.2 Allogene Therapeutics Business Overview
11.14.3 Allogene Therapeutics Drug based on CAR T-Cell Introduction
11.14.4 Allogene Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.14.5 Allogene Therapeutics Recent Developments
11.15 Celyad
11.15.1 Celyad Company Details
11.15.2 Celyad Business Overview
11.15.3 Celyad Drug based on CAR T-Cell Introduction
11.15.4 Celyad Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.15.5 Celyad Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug based on CAR T-Cell Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of CD19-targeted
Table 3. Key Players of BCMA-targeted
Table 4. Global Drug based on CAR T-Cell Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Drug based on CAR T-Cell Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drug based on CAR T-Cell Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Drug based on CAR T-Cell Market Share by Region (2018-2024)
Table 8. Global Drug based on CAR T-Cell Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drug based on CAR T-Cell Market Share by Region (2024-2029)
Table 10. Drug based on CAR T-Cell Market Trends
Table 11. Drug based on CAR T-Cell Market Drivers
Table 12. Drug based on CAR T-Cell Market Challenges
Table 13. Drug based on CAR T-Cell Market Restraints
Table 14. Global Drug based on CAR T-Cell Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Drug based on CAR T-Cell Revenue Share by Players (2018-2024)
Table 16. Global Top Drug based on CAR T-Cell by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2022)
Table 17. Global Drug based on CAR T-Cell Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Drug based on CAR T-Cell Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Drug based on CAR T-Cell, Headquarters and Area Served
Table 20. Global Key Players of Drug based on CAR T-Cell, Product and Application
Table 21. Global Key Players of Drug based on CAR T-Cell, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug based on CAR T-Cell Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Drug based on CAR T-Cell Revenue Market Share by Type (2018-2024)
Table 25. Global Drug based on CAR T-Cell Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drug based on CAR T-Cell Revenue Market Share by Type (2024-2029)
Table 27. Global Drug based on CAR T-Cell Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Drug based on CAR T-Cell Revenue Share by Application (2018-2024)
Table 29. Global Drug based on CAR T-Cell Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drug based on CAR T-Cell Revenue Share by Application (2024-2029)
Table 31. North America Drug based on CAR T-Cell Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Drug based on CAR T-Cell Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Drug based on CAR T-Cell Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Drug based on CAR T-Cell Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Drug based on CAR T-Cell Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Drug based on CAR T-Cell Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Drug based on CAR T-Cell Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Drug based on CAR T-Cell Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Drug based on CAR T-Cell Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Drug based on CAR T-Cell Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Drug based on CAR T-Cell Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Drug based on CAR T-Cell Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Drug based on CAR T-Cell Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Drug based on CAR T-Cell Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Drug based on CAR T-Cell Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Drug based on CAR T-Cell Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Drug based on CAR T-Cell Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Drug based on CAR T-Cell Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Drug based on CAR T-Cell Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Drug based on CAR T-Cell Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Drug based on CAR T-Cell Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drug based on CAR T-Cell Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Drug based on CAR T-Cell Product
Table 66. Novartis Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 67. Novartis Recent Developments
Table 68. Gilead Sciences Company Details
Table 69. Gilead Sciences Business Overview
Table 70. Gilead Sciences Drug based on CAR T-Cell Product
Table 71. Gilead Sciences Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 72. Gilead Sciences Recent Developments
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Drug based on CAR T-Cell Product
Table 76. Bristol-Myers Squibb Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Developments
Table 78. J & J Company Details
Table 79. J & J Business Overview
Table 80. J & J Drug based on CAR T-Cell Product
Table 81. J & J Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 82. J & J Recent Developments
Table 83. JW Therapeutics Company Details
Table 84. JW Therapeutics Business Overview
Table 85. JW Therapeutics Drug based on CAR T-Cell Product
Table 86. JW Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 87. JW Therapeutics Recent Developments
Table 88. FOSUNKite Company Details
Table 89. FOSUNKite Business Overview
Table 90. FOSUNKite Drug based on CAR T-Cell Product
Table 91. FOSUNKite Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 92. FOSUNKite Recent Developments
Table 93. CARsgen Therapeutics (Pipeline) Company Details
Table 94. CARsgen Therapeutics (Pipeline) Business Overview
Table 95. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product
Table 96. CARsgen Therapeutics (Pipeline) Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 97. CARsgen Therapeutics (Pipeline) Recent Developments
Table 98. CARsgen Therapeutics Company Details
Table 99. CARsgen Therapeutics Business Overview
Table 100. CARsgen Therapeutics Drug based on CAR T-Cell Product
Table 101. CARsgen Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 102. CARsgen Therapeutics Recent Developments
Table 103. Autolus Therapeutics Company Details
Table 104. Autolus Therapeutics Business Overview
Table 105. Autolus Therapeutics Drug based on CAR T-Cell Product
Table 106. Autolus Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 107. Autolus Therapeutics Recent Developments
Table 108. Sorrento Therapeutics Company Details
Table 109. Sorrento Therapeutics Business Overview
Table 110. Sorrento Therapeutics Drug based on CAR T-Cell Product
Table 111. Sorrento Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 112. Sorrento Therapeutics Recent Developments
Table 113. Mustang Bio Company Details
Table 114. Mustang Bio Business Overview
Table 115. Mustang Bio Drug based on CAR T-Cell Product
Table 116. Mustang Bio Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 117. Mustang Bio Recent Developments
Table 118. Bluebird Bio Company Details
Table 119. Bluebird Bio Business Overview
Table 120. Bluebird Bio Drug based on CAR T-Cell Product
Table 121. Bluebird Bio Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 122. Bluebird Bio Recent Developments
Table 123. Cellectis Company Details
Table 124. Cellectis Business Overview
Table 125. Cellectis Drug based on CAR T-Cell Product
Table 126. Cellectis Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 127. Cellectis Recent Developments
Table 128. Allogene Therapeutics Company Details
Table 129. Allogene Therapeutics Business Overview
Table 130. Allogene Therapeutics Drug based on CAR T-Cell Product
Table 131. Allogene Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 132. Allogene Therapeutics Recent Developments
Table 133. Celyad Company Details
Table 134. Celyad Business Overview
Table 135. Celyad Drug based on CAR T-Cell Product
Table 136. Celyad Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 137. Celyad Recent Developments
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug based on CAR T-Cell Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Drug based on CAR T-Cell Market Share by Type: 2022 VS 2029
Figure 3. CD19-targeted Features
Figure 4. BCMA-targeted Features
Figure 5. Global Drug based on CAR T-Cell Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Drug based on CAR T-Cell Market Share by Application: 2022 VS 2029
Figure 7. Lymphoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. Drug based on CAR T-Cell Report Years Considered
Figure 10. Global Drug based on CAR T-Cell Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Drug based on CAR T-Cell Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Drug based on CAR T-Cell Market Share by Region: 2022 VS 2029
Figure 13. Global Drug based on CAR T-Cell Market Share by Players in 2022
Figure 14. Global Top Drug based on CAR T-Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Drug based on CAR T-Cell Revenue in 2022
Figure 16. North America Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Drug based on CAR T-Cell Market Share by Type (2018-2029)
Figure 18. North America Drug based on CAR T-Cell Market Share by Application (2018-2029)
Figure 19. North America Drug based on CAR T-Cell Market Share by Country (2018-2029)
Figure 20. United States Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Drug based on CAR T-Cell Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe Drug based on CAR T-Cell Market Share by Type (2018-2029)
Figure 24. Europe Drug based on CAR T-Cell Market Share by Application (2018-2029)
Figure 25. Europe Drug based on CAR T-Cell Market Share by Country (2018-2029)
Figure 26. Germany Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China Drug based on CAR T-Cell Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China Drug based on CAR T-Cell Market Share by Type (2018-2029)
Figure 34. China Drug based on CAR T-Cell Market Share by Application (2018-2029)
Figure 35. Asia Drug based on CAR T-Cell Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia Drug based on CAR T-Cell Market Share by Type (2018-2029)
Figure 37. Asia Drug based on CAR T-Cell Market Share by Application (2018-2029)
Figure 38. Asia Drug based on CAR T-Cell Market Share by Region (2018-2029)
Figure 39. Japan Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America Drug based on CAR T-Cell Market Share by Country (2018-2029)
Figure 49. Brazil Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Novartis Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 56. Gilead Sciences Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 58. J & J Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 59. JW Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 60. FOSUNKite Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 61. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 62. CARsgen Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 63. Autolus Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 64. Sorrento Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 65. Mustang Bio Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 66. Bluebird Bio Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 67. Cellectis Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 68. Allogene Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 69. Celyad Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed